@article{4f090093a75246d9b387bbdef31fc25c,
title = "Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial",
abstract = "Resistance from antagonistic muscle groups might be a crucial factor reducing function in chronic hemiparesis. The resistance due to spastic co-contraction might be reduced by botulinum toxin injections. We assessed the effects of abobotulinumtoxinA injection in the upper limb muscles on muscle tone, spasticity, active movement, and function.",
keywords = "Acetylcholine Release Inhibitors, Adult, Botulinum Toxins, Type A, Brain Injuries, Double-Blind Method, Female, Humans, Injections, Intramuscular, Male, Middle Aged, Muscle Spasticity, Paresis, Stroke, Treatment Outcome, Upper Extremity, Acetylcholine Release Inhibitors, Adult, Botulinum Toxins, Type A, Brain Injuries, Double-Blind Method, Female, Humans, Injections, Intramuscular, Male, Middle Aged, Muscle Spasticity, Paresis, Stroke, Treatment Outcome, Upper Extremity",
author = "Bentivoglio, {Anna Rita}",
year = "2015",
doi = "10.1016/S1474-4422(15)00216-1",
language = "English",
volume = "14",
pages = "992--1001",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Lancet Limited:42 Bedford Square, London WC1B 3SL United Kingdom:011 44 207 4364981, EMAIL: custserv@lancet.com, INTERNET: http://www.thelancet.com, Fax: 011 44 207 3236433",
}